Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 1740-1744, April 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spear, G. T.
Right arrow Articles by Borden, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spear, G. T.
Right arrow Articles by Borden, E. C.

Requirement of Differentiative Signals of Both Interferon-{gamma} and 1,25-Dihydroxyvitamin D3 for Induction and Secretion of Interleukin-1 by HL-60 Cells

Gregory T. Spear1, Donna M. Paulnock2, Diane O. Helgeson and Ernest C. Borden3

Departments of Human Oncology and Medical Microbiology, University of Wisconsin, Clinical Cancer Center, Madison, Wisconsin 53792

HL-60, a promyelocytic cell line, was treated with both recombinant interferon-gamma (IFN-{gamma}) and 1,25-(OH)2 vitamin D3 (D3), and the effect on monocyte-specific markers was assessed. IFN-{gamma} and D3 modulated different stages in the monocytic differentiation with respect to interleukin-1 (IL-1) production and secretion. D3 induced production of an intracellular IL-1 activity that was not secreted after lipopolysaccharide stimulation. IFN-{gamma} did not induce intracellular IL-1 but differentiated HL-60 cells, which had been treated with D3, so that lipopolysaccharide stimulated IL-1 release. Both D3 and IFN-{gamma} individually enhanced expression of nonspecific esterase; in combination the two agents potentiated each other. Expression of cell surface Leu-M3 antigen was also enhanced by the combination of these two agents. Thus, IFN-{gamma} not only potentiated expression of D3-induced markers but also conferred phenotypic properties characteristic of monocytes. IFN-{gamma} may play a role in the differentiation of bone marrow cells to mature monocytes.

1 Supported in part by a Triton Biosciences Research Fellowship.

2 Shaw Scholar.

3 American Cancer Society Professor of Clinical Oncology. To whom requests for reprints should be addressed, at Department of Human Oncology, K4/410 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792.

Received 6/10/87. Revised 12/15/87. Accepted 12/28/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.